Viridian Therapeutics, Inc./DE Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Viridian Therapeutics, Inc./DE (VRDN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 16.61 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 16.61M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 16.75M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 14.47M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 14.50M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 16.61M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 16.75M shares 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 14.47M shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 14.50M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 13.90M shares 10-Q · filed 2025-08-06 | |
| 2025-03-31 | 14.12M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 11.35M shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 11.35M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 10.99M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 10.32M shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 11.53M shares 10-K · filed 2024-02-27 | |
| 2023-09-30 | 8.26M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 8.39M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 7.88M shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 5.72M shares 10-K · filed 2023-03-09 | |
| 2022-09-30 | 5.43M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 5.41M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 4.80M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 3.68M shares 10-K · filed 2022-03-11 | |
| 2021-09-30 | 3.37M shares 10-Q · filed 2021-11-05 | |
| 2021-06-30 | 2.70M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 3.15M shares 10-Q · filed 2021-05-07 | |
| 2020-12-31 | 1.03M shares 10-K · filed 2021-03-26 | |
| 2016-12-31 | 37.47K shares 10-K · filed 2017-03-24 | |
| 2016-09-30 | 580.94K shares 10-Q · filed 2016-10-26 | |
| 2016-06-30 | 622.84K shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 580.96K shares 10-Q · filed 2016-05-16 | |
| 2015-12-31 | 42.10K shares 10-K · filed 2017-03-24 | 631.57K shares 10-K · filed 2016-03-21 |
| 2015-09-30 | 653.80K shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 179.00K shares 10-Q · filed 2015-08-14 | |
| 2015-03-31 | 180.00K shares 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 152.00K shares 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |